中药复方治疗干燥综合征的配伍规律及作用机制研究

doi:10.19803/j.1672-8629.20230429

摘要/Abstract

摘要： 目的通过国家专利数据库,运用数据挖掘方法总结中药复方专利治疗干燥综合征（SS）的配伍特点及用药规律,根据网络药理学的分析方法,对高频药物治疗SS的潜在作用靶点及分子机制进行预测。方法登录“中国专利公布公告”网站检索并筛选建库至2022年12月10日治疗SS的中药复方专利数据。应用 Microsoft Excel 2022、IBM SPSS Modeler 18.0 等软件,对所纳入的专利复方进行频次统计、关联规则和聚类分析。利用中药系统药理学数据库（TCMSP）平台,获得中药化学成分及其潜在靶点并归纳分析;应用人类孟德尔遗传（OMIM）数据库、GeneCards等数据库对SS相关疾病靶点进行筛选,同时绘制韦恩图找到药物靶点与SS靶点的交集靶点,运用蛋白质相互作用数据库（STRING）构建蛋白质相互作用网络,并筛选出其最终的核心作用靶点;并登录Metascape 网站寻找核心作用靶点富集的通路及其功能。结果根据对国家专利数据库的筛选结果,共得到69项符合条件的用于治疗SS的中药复方专利,其中包含353味药物,排名位于前5位的高频核心药物分别为麦冬、地黄、甘草、石斛、白芍;这5味药物共涉及161个化合物、1 585个相关作用靶点,干燥综合征相关靶点1 058个,中药与疾病共同靶点挖掘 81个、核心靶点 28个;通过富集分析得到京都基因与基因组百科全书（KEGG）通路 177 条,主要包括IL-17信号通路、PD-1/PD-L1通路,JAK-STAT信号通路等;基因本体（GO）生物工程（BP）3 106条,主要涉及细胞对生物刺激因素、脂多糖反应、对细胞因子产生的正向调节的过程等;GO细胞组成（CC）193条主要涉及质膜外侧、膜微区等;GO分子功能（MF）289条主要涉及生长因子受体、受体配体活性等。结论中药复方专利治疗SS总以滋阴润燥,养阴生津为主。核心药物治疗SS具有多成分、核心靶点、多条通路相互协同特点,并且与IL-6、MMP3、SATA3、TNF等靶点关系密切,可能通过 IL-17、PD-1/PD-L1通路等信号通路发挥作用,并为后续SS临床治疗提供新的用药参考及研究方向,也为中医药防治SS应用提供参考及分子生物学基础。

关键词: 干燥综合征, 中药复方, 数据挖掘, 网络药理学, 配伍规律, 麦冬, 地黄, 甘草, 石斛, 白芍

Abstract: Objective To analyze the ways in which Chinese medicinal compound formulas are used in the treatment of Sjogren's syndrome based on the National Patent Database and to predict the potential targets of action and molecular mechanisms of high frequency drugs in the treatment of Sjogren's syndrome using analytical methods of network pharmacology. Methods Data on patent Chinese medicinal compound formulas for treating Sjogren's syndrome was retrieved from the Chinese Patent Search Database as of December 10, 2022. Microsoft Excel 2022 and IBM SPSS Modeler 18.0 were used to analyze these included compounds in terms of frequency, correlations and clustering analysis. The chemical components of TCM and their potential targets were retrieved from the Traditional Chinese Medicine Systematic Pharmacology Database (TCMSP) platform. OMIM and GeneCards were used to screen the Sjogren' Syndrome-related disease targets. The Venny diagram was drawn to identify the intersection targets of high-frequency drugs and Sjogren's syndrome targets. The protein interaction network was constructed while the final core targets were screened by using the STRING database. The Metascape website was used to find the pathways and functions of high core target enrichment. Results According to the screening results via the national patent database, 69 eligible Chinese medicine compound patents for the treatment of Sjogren's syndrome were obtained, including 353 drugs, and the top 5 high-frequency drugs were Maidong(Dwarf Lilyturf Tuber), Dihuang (Rehmanniae Radix), Gancao (Licorice), Shihu (Dendrobium nobile Lindl) and Baishao (White Peony Root). These five drugs involved 161 compounds and 1 585 related targets, 1 058 targets related to the Sjogren's syndrome, 81 treatment targets and 28 core targets. Through enrichment analysis, 177 KEGG pathways were obtained, including IL-17 signaling pathway, PD-1/PD-L1 pathway and JAK-STAT signaling pathway. A total of 3 106 GO biological processes (BPs) were retrieved, involving cellular responses to biological stimuli and lipopolysaccharides and the processes of positive regulation of cytokine production. The 193 GO cellular components (CCs) involved the outer plasma membrane and membrane microregions. Conclusion Sjogren' Syndrome is generally treated with Chinese medicinal compound formulas by nourishing Yin, moistening dryness and generating fluid. The medications for Sjogren's Syndrome have multi-component, multi-target and multi-pathway properties and are closely related to IL-6, MMP3, SATA3 and TNF possibly through IL-17, PD-1/PD-L1 pathways. This study is expected to provide reference for subsequent clinical treatment of Sjogren's syndrome.

Key words: Sjogren's syndrome, Chinese medicinal compound formulas, data mining, network pharmacology, law of compatibility, Maidong, Dihuang, Gancao, Shihu, Baishao

中图分类号:

R965.2

茹尘, 侯秀娟, 钱唐亮, 杜梦梦, 李媛, 刘小平, 朱跃兰. 中药复方治疗干燥综合征的配伍规律及作用机制研究[J]. 中国药物警戒, 2024, 21(4): 397-403.

RU Chen, HOU Xiujuan, QIAN Tangliang, DU Mengmeng, LI Yuan, LIU Xiaoping, ZHU Yuelan. Compatibility and mechanism of a Chinese medicine compound in treating Sjogren's syndrome[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 397-403.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://www.zgywjj.com/CN/10.19803/j.1672-8629.20230429

https://www.zgywjj.com/CN/Y2024/V21/I4/397

参考文献

[1] LONGOBARDI S, LOPEZ-DAVIS C, KHATRI B, et al.Autoantibodies identify primary Sjögren's syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B[J]. Ann Rheum Dis, 2023, 82(9): 1181-1190.
[2] FOX RI, FOX CM, GOTTENBERG JE, et al.Treatment of sjögren's syndrome: current therapy and future directions[J]. Rheumatology (Oxford), 2021, 60(5): 2066-2074.
[3] GOULES AV, TZIOUFAS AG.Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers[J]. Immunol Res, 2017, 65(1): 331-344.
[4] XIU WW, WANG Y.Discussion on the etiology and mechanism of Sjogren syndrome in Chinese medicine[J]. Journal of Sichuan of Traditional Chinese Medicine(四川中医), 2014, 32(3): 16-17.
[5] State Administration of Traditional Chinese Medicine“Chinese Materia Medica”Editorial Committee. Chinese Materia Medica(中华本草)[M]. Shanghai: Shanghai University of Science and Technology Press, 1999.
[6] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China, Volume I(中华人民共和国药典一部) [M]. Beijing: China Medical Science Press, 2020.
[7] GAO XM, ZHANG TM, ZHANG JR, et al.Chinese Materia Medica(中药学) [M]. Beijing: China Press of Traditional Chinese Medicine, 2007.
[8] RU JL, LI P, WANG JN, et al.TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. Journal of Cheminformatics, 2014, 6(1): 1-6.
[9] CONSORTIUM TU, BATEMANA, MARTIN MJ, et al.UniProt: the universal protein knowledgebase[J]. Nucleic Acids Research, 2016, 45(D1): D158-D169.
[10] REBHAN M, CHALIFA-CASPI V, PRILUSKY J, et al.GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support[J]. Bioinformatics, 1998, 14(8): 656-664.
[11] SZKLARCZYK D, GABLE AL, LYON D, et al.STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets[J]. Nucleic Acids Research, 2018, 47(D1): D607-D613.
[12] SHANNON P, MARKIEL A, OZIER O, et al.Cytoscape: a software environment for integrated models of biomolecular interaction networks[J]. Genome Research, 2003, 13(11): 2498-2504.
[13] ZHOU YY, ZHOU B, PACHE L, et al.Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J]. Nature Communications, 2019, 10(1): 1-10.
[14] SUN J, ZOU Y, JIANG P.Discussing the rules of diagnosis and treatment of dry syndrome based on“treating qi, increasing fluid and treating blood”[J]. Journal of Basic Chinese Medicine, 2023, 29(8): 1268-1271.
[15] HARRIS JA, HUANG K, MILOSLAVSKY E, et al.Sicca syndrome associated with immune checkpoint inhibitor therapy[J]. Oral Dis, 2022, 28(8): 2083-2092.
[16] THORLACIUS GE, BJÖRK A, WAHREN-HERLENIUS M. Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies[J]. Nat Rev Rheumatol, 2023, 19(5): 288-306.
[17] WANG JMM, GUO XN, FENG WS, et al.Progress in the study of pharmacological effects of polysaccharides and oligosaccharides of Radix Rehmanniae spp[J]. Chinese Journal of Gerontology(中国老年学杂志), 2015, 35(22): 6603-6605.
[18] JU XK, TAO QW, SUN JR, et al.Exploring the mechanism of action of Paeonia lactiflora in the treatment of primary Sjogren's Syndrome based on network pharmacology[J]. Journal of China-Japan Friendship Hospital(中日友好医院学报), 2021, 35(5): 291-293.
[19] HUANG JB, DING J, ZHU HM, et al.Comparison of polysaccharides from three different seed sources of Dendrobium officinale and their preliminary pharmacological activity evaluation[J]. Science and Technology of Food Industry(食品工业科技), 2022, 43(5): 71-78.
[20] FANG MM, ZHANG JY, ZHANG XL, et al.Progress in the study of chemical composition and pharmacological effects of MaiDong[J]. Information on Traditional Chinese Medicine(中医药信息), 2020, 37(4): 130-134.
[21] DU HX.Protective effect of glycyrrhizin against Alzheimer's disease by inhibiting inflammatory response and its mechanism study[D]. Chongqing: Chongqing Medical University(重庆医科大学), 2019.
[22] ZHANG LN, YAO CH, LUO J, et al.A Meta-experience of primary Sjogren's Syndrome treated by traditional Chinese medicine[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2021, 36(5): 2588-2592.
[23] CHEN JQ, YANG JY, WU ZH, et al.Analysis of Chinese medicine syndromic characteristics and related factors in primary Sjogren's syndrome combined with interstitial lung disease[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2023, 29(8): 66-72.
[24] RENG ZX, WANG WR, YANG XP, et al.Discussion on the academic theory of five-liquid identification in the diagnosis and treatment of Sjogren's syndrome by Yan Xiaoping[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2019, 34(9): 4090-4092.
[25] LUO J, WU ZH, TAO QW.Exploring the etiology and pathogenesis of primary Sjogren's Syndrome from dryness-dampness homoeopathy[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2023, 38(7): 3154-3157.
[26] YANG F, XU JX, WEI N.Essence of Prof. Zhu Yueran's experience in the treatment of Sjogren's syndrome[J]. Global Traditional Chinese Medicine(环球中医药), 2018, 11(10): 1550-1553.
[27] WANG HY, ZHANG YT, BAI ZY, et al.Effects of blood-activating and detoxifying formula on intestinal flora of NOD mice[J]. Journal of Traditional Chinese Medicine(中医杂志), 2022, 63(1): 56-63.
[28] LI ZB, ZHOU Q, ZHANG GS, et al.Treatment of primary Sjogren's syndrome by combining Sha Shen Maitong Tang with Bai Shao Zuosu capsules based on the theory of fluid metabolism[J]. Chinese Journal of Experimental Traditional Medical Formulae(中国实验方剂学杂志), 2020, 26(20): 100-104.
[29] BAI ZY, ZHAO D, DU Y, et al.Discussion on the pathogenesis and treatment of desiccation syndrome based on the principle of “clear yang out of the upper orifices”[J]. Journal of Liaoning University of Traditional Chinese Medicine(辽宁中医药大学学报), 2022, 24(10): 90-93.
[30] ZHANG R, WANG H, MOU N, et al.Correlation between clinical indicators and IL-1ators and IL-1indicators and IL-1d IL-1ciple of“clear yang out of Sjogren's syndrome[J]. Journal of Medical Research(医学研究杂志), 2021, 50(10): 88-92.
[31] MAVRAGANI CP, MOUSTOPLULOS HM.Sjögren's syndrome: old and new therapeutic targets[J]. J Autoimmun, 2020,11(10): 10-13.
[32] WU GL, LI TY, PU XH, et al.Effects of nourishing yin, benefiting qi and activating blood prescription on the expression of TNF. Journal of Liaoning Unisjogren's syndrome[J]. Chinese Journal of Chinese Materia Medica(中国中医杂志), 2013, 38(3): 413-416.
[33] LOPEZ-MIGUEL A, TESON M, MATIN-MONTAZEN V, et al.Clinical and molecular inflammatory response in Sjögren syndrome-associated dry eye patients under desiccating stress[J]. Am J Ophthalmol, 2016, 21(11): 133-136.
[34] GUO GL.Clinical observation and network pharmacology study on the treatment of primary dry syndrome with qi deficiency and fluid deficiency by moistening dry drink[D]. Beijing: China Academy of Traditional Chinese Medicine(中国中医科学院), 2021.
[35] HONG X, MENG S, TANG D, et al.Single-Cell RNA sequencing reveals the expansion of cytotoxic CD4+ T lymphocytes and a landscape of immune cells in primary Sjögren's syndrome[J]. Front Immunol, 2021, 2(11): 59-62.
[36] LIANG Y, ZHANG Z, LI J, et al.Association between IL-17 and primary Sjögren's syndrome: a single-center study and a systematic scoping review[J]. Int Immunopharmacol, 2022, 11(5): 107-108.
[37] ZHOU J, YU Q.Anti-IL-17 receptor-α-treatmentameliorates newly established Sjögren's-like exocrinopathy in non-obese diabetic mice[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(7): 2438-2447.
[38] ZHANG S, QU J, WANG L, et al.Activation of toll-like receptor signaling pathway in primary Sjögren's syndrome-associated thrombocytopenia[J]. Front Immunol, 2021, 9(12): 63-69.
[39] KIM JW, LEE J, HONG SM, et al.Circulating CCR7^loPD-1^hi follicular helper T cells indicate disease activity and glandular inflammation in patients with primary Sjögren's syndrome[J]. Immune Netw, 2019, 19(4): e20-e26.
[40] LI M, LI M, QIAO L, et al.Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome[J]. Chin Med J (Engl), 2023, 136(19): 2297-2306.
[41] ZHOU XR, JIANG Q, TANG XP, et al.Expert consensus on Chinese medicine evidence of Sjogren's syndrome[J]. Journal of Beijing University of Traditional Chinese Medicine(北京中医药大学学报), 2023, 46(3): 310-314.
[42] YANG XY, GAN K, LU Y.Overview of the research on Chinese medicine diagnosis and typing and clinical application of Sjogren's syndrome[J]. Clinical Journal of Traditional Chinese Medicine(中医药临床杂志), 2023, 35(3): 600-604.